New Regs for RX Ads on the Way?

december 4, 2003  08:38 am
The Federal Trade Commission wants the Federal Drug Administration to drop its requirements that pharmaceutical print ads run detailed drug side-effects listings. Instead, it wants drug companies to be allowed to use the same kind of "brief summary" risk warnings in print ads that are now used in broadcast commercials.